systematic review meta-analysis network meta-analysis

Select advanced breast cancer (metastatic) All type of patient       capecitabine containing regimenchemotherapy comparisoncontinuous vs intermittentgemcitabine regimeninitial chemotherapylongmaintenance CTmore cycles of chemotherapyplatin containing CT capecitabine cisplatin gemcitabine vs CTvs observationvs taxane containing regimen      

Filter

Group by Group by... nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition MA  in first nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in second nothing pathology treatment patient comparator classe classe comparator mechanism clinical condition  in third	Description Synopsis Comparison Treatments Patients Characteristics Method Risk of bias References None Tools Indexation					Results Global trial result Main results All results All result tag NCT results	death (overall survival) (11) Options Numeric bar chart forest plot medians
Trial	Studied trt	Control trt	patients	tags	ROB	Trial result	death (overall survival)
advanced breast cancer (metastatic)
capecitabine
Oshaughnessy, 2001	capecitabine	CMF				-
Stockler, 2011	capecitabine	cyclophosphamide, methotrexate, and 5-fluorouracil				-
GeparQuattro, 2010      NCT	capecitabine docetaxel	docetaxel				-
Mavroudis, 2010	capecitabine	docetaxel + epirubicin				-
Verma, 2005	capecitabine + docetaxel	docetaxel alone				-
Miles, 2004	capecitabine + docetaxel	docetaxel alone				-
O'Shaughnessy, 2002	capecitabine + docetaxel	docetaxel alone				-
Hori	capecitabine MPA	IV CT				-
Talbot, 2002	capecitabine	paclitaxel				-
Moiseenko, 2000	capecitabine	paclitaxel				-
Jäger, 2010	capecitabine	pegylated liposomal doxorubicin				-
EORTC 10001 (Pajk), 2008	capecitabine	vinorelbine				-
cisplatin
Costanza, 1999	carboplatin followed by CAF	CAF				suggesting
Creagan ET, 1984	CAP	CFP				suggesting
Cocconi, 1991	cisplatin + etoposide	CMF				suggesting
Cocconi, 1999	CMF, cisplatin, etoposide, and doxorubicin	CMF				suggesting
Cocconi G, 1996	MPEPIV or MPEMi	CMF				suggesting
Kolaric, 1985	CAP	CMFVP				suggesting
Eisen, 1998	EcisF	ECycloF				negative
Nielsen, 2000	EPI + CIS	EPI				suggesting
Kolaric, 1989	CAP	FAC				suggesting
Berruti A, 2002	cisplatin + epirubicin	lonidamine + epirubicin				negative
Berruti B, 2002	cisplatin + epirubicin	lonidamine + epirubicin				suggesting
Icli, 2002	VP-16+P	paclitaxel				suggesting
Fountzilas, 2002	PCb	PE				negative
gemcitabine
Seidman, 2011	gemcitabine + docetaxel	capecitabine + docetaxel				-
Chan, 2009	gemcitabine + docetaxel	capecitabine plus docetaxel				-
Nielsen, 2011	gemcitabine + docetaxel	docetaxel				-
Feher, 2005	gemcitabine	epirubicin				-
Brufsky, 2011	gemcitabine + paclitaxel + bevacizumab	paclitaxel + bevacizumab				-
Albain, 2008	gemcitabine + paclitaxel	paclitaxel monotherapy				-
Martín, 2007	gemcitabine + vinorelbine	vinorelbine monotherapy				-
Papadimitriou, 2009	gemcitabine + weekly docetaxel	weekly docetaxel				-